CWMK
JAZZ icon

Caliber Wealth Management (Kansas)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Caliber Wealth Management (Kansas)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205K Sell
850
-415
-33% -$90.9K 0.02% 294
2026
Q1 		$239K Sell
1,265
-504
-28% -$88.1K 0.03% 244
2025
Q4 		$301K Sell
1,769
-409
-19% -$62.7K 0.03% 216
2025
Q3 		$287K Sell
2,178
-846
-28% -$101K 0.03% 211
2025
Q2 		$321K Buy
3,024
+745
+33% +$80.9K 0.03% 224
2025
Q1 		$283K Buy
+2,279
New +$297K 0.04% 202

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caliber Wealth Management (Kansas)'s JAZZ Position: Q2 2026 in Review

Caliber Wealth Management (Kansas) reduced its Jazz Pharmaceuticals (JAZZ) stake by 33% in Q2 2026, selling an estimated $90.9K and leaving 850 shares worth $205K. The position accounts for 0.02% of the portfolio, ranked #294.

Caliber Wealth Management (Kansas) first reported a position in JAZZ in Q1 2025 and has held it in 6 quarters since. The position peaked at $321K in Q2 2025. 106 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Caliber Wealth Management (Kansas) held 850 shares of Jazz Pharmaceuticals worth $205K as of Q2 2026.
  • Caliber Wealth Management (Kansas) sold 415 Jazz Pharmaceuticals shares in Q2 2026, an estimated $90.9K.
  • Jazz Pharmaceuticals made up 0.02% of Caliber Wealth Management (Kansas)'s portfolio in Q2 2026, its #294 holding.
  • Caliber Wealth Management (Kansas) first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Caliber Wealth Management (Kansas)'s Jazz Pharmaceuticals position peaked at $321K in Q2 2025.
  • 106 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Caliber Wealth Management (Kansas)'s 13F filing for Q2 2026, filed 22 Jul 2026.